# The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope

> **NCT01357967** · PHASE4 · UNKNOWN · sponsor: **Inje University** · enrollment: 60 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** SSRI monotherapy
- **DRUG:** Seroquel XR adjunctive

## Key facts

- **NCT ID:** NCT01357967
- **Lead sponsor:** Inje University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-05
- **Primary completion:** 2012-12
- **Final completion:** 2013-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2012-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01357967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01357967, "The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01357967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*